Improved Glaucoma Medication Adherence in a Randomized Controlled Trial.


Journal

Ophthalmology. Glaucoma
ISSN: 2589-4196
Titre abrégé: Ophthalmol Glaucoma
Pays: United States
ID NLM: 101730510

Informations de publication

Date de publication:
Historique:
received: 05 03 2021
revised: 08 04 2021
accepted: 14 04 2021
pubmed: 24 4 2021
medline: 22 4 2022
entrez: 23 4 2021
Statut: ppublish

Résumé

To test the effectiveness of an intervention designed to improve glaucoma medication adherence. Randomized, controlled trial at a Veterans Affairs (VA) eye clinic. Veterans with medically treated glaucoma who reported poor adherence and their companions if applicable. Participants, and their companions if applicable, were randomized to receive an intervention to improve medication adherence that included glaucoma education, personalized disease management suggestions, and a reminder aid, or the control arm that received education regarding general eye health. The average proportion of prescribed glaucoma medication doses taken on schedule over the 6 months after randomization according to an electronic monitor between participants in the 2 arms. The mean proportion of prescribed doses taken on schedule was higher in the intervention group compared with controls (0.85 vs. 0.62, P < 0.0001). The difference in proportions between the 2 groups did not vary in regressions models adjusted for companion status, frequency of dosing, and race. The longitudinal model indicated that the intervention group had significantly higher adherence during the first month after randomization and continued to stay higher through 6 months (month by treatment interaction, P = 0.003). A multifaceted intervention can help improve glaucoma medication adherence.

Identifiants

pubmed: 33892170
pii: S2589-4196(21)00096-X
doi: 10.1016/j.ogla.2021.04.006
pii:
doi:

Substances chimiques

Ophthalmic Solutions 0

Banques de données

ClinicalTrials.gov
['NCT03052257']

Types de publication

Journal Article Randomized Controlled Trial Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

40-46

Subventions

Organisme : HSRD VA
ID : I01 HX001893
Pays : United States
Organisme : HSRD VA
ID : IK6 HX003161
Pays : United States

Informations de copyright

Copyright © 2021 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Auteurs

Kelly W Muir (KW)

Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina; Durham Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, Durham, North Carolina. Electronic address: kelly.muir@duke.edu.

Jullia A Rosdahl (JA)

Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina.

Aaron M Hein (AM)

Department of Medicine, Duke University School of Medicine, Durham, North Carolina.

Sandra Woolson (S)

Durham Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, Durham, North Carolina.

Maren K Olsen (MK)

Durham Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, Durham, North Carolina; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina.

Miriam Kirshner (M)

Durham Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, Durham, North Carolina.

Malina Sexton (M)

Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina.

Hayden B Bosworth (HB)

Department of Medicine, Duke University School of Medicine, Durham, North Carolina; Department of Population Health Sciences, Duke University, Durham, North Carolina; Durham Center of Innovation to Accelerate Discovery and Practice Transformation, Durham Veterans Affairs Health Care System, Durham, North Carolina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH